Resources

On December 29, 2022, Congress passed the Mainstreaming Addiction Treatment (MOUD) and Medication Access and Training Expansion (MOUDE) Acts to:

  1. expand access to Buprenorphine for the treatment of opioid use disorder, and
  2. normalize and enhance substance use care across healthcare settings.

These new mandates will help to expand the use of Buprenorphine in different settings. The Maryland Addiction Consultation website has been updated with a page dedicated to the MOUDE/MOUD acts. https://www.marylandmacs.org/MOUD–MOUDE-Acts/

 

Funding Opportunities

Buprenorphine Initiative

The purpose of these funds will be to increase access to Buprenorphine medications for Calvert County residents. The LBHA of Calvert County will be monitoring the application and reimbursement process for Buprenorphine medication purchases.

Medication Request

Individuals seeking financial assistance with purchasing their Buprenorphine medication due to being uninsured or underinsured may receive this funding. The prescribing MOUD provider must be the person who fills out and signs the application in order to obtain funding. Providers can access the application

here and send the finalized copy to Katie Wandishin at mdh-dl-calchd-coreservicescchd@maryland.gov

 

Educational Resources

The Calvert County Local Behavioral Health Authority hosted “Community Conversations: Calvert County’s Innovations on Addressing Substance Use Disorders,” on December 15, 2021 at the Chesapeake Beach Community Center in Chesapeake Beach, MD.

This event featured a presentation by Dr. Drew Fuller, the Medical Director of the Calvert Crisis Response Mobile Crisis Team, along with a panel discussion and Q&A session with community specialists and local government representatives on evidence-based treatment options available in Calvert County.

You can watch the presentation below:

 

Other Great Resources to Learn More About MOUD

SAMHSA Medication Assisted Treatment

Maryland MACS

CDC Rx Awareness

The ASAM National Practice Guideline For the Treatment of OUD

MDH Prescription Drug Monitoring Program

FDA Information about Medication-Assisted Treatment

PhRMA Medicine Assistance Tool